2-DG was developed by the Defence Research and Development Establishment (DRDE), Gwalior. The clinical trials were conducted by the Institu...

Shares of Bajaj Healthcare surged 11 per cent in early trade on Thursday after the company received license from Defence Research and Devel...

In the initial weeks, the company will make the drug available in hospitals across metros and Tier 1 cities, and subsequently expand covera...

Disclosing this on Tuesday evening, the DRDO chairman Dr G Satheesh Reddy said the EoIs were called from the interested Indian pharmaceutic...

The Drugs Controller General of India (DCGI) approved the 2-deoxy-D-glucose (2-DG) drug for emergency use as an adjunct therapy in moderate...

The Niti Aayog Member's remarks on allopathy and ayurveda comes against the backdrop of the Indian Medical Association (IMA) raising strong...

The first batch of DRDO's anti-Covid-19 drug was released on May 17 by Defence Minister Rajnath Singh and health minister Dr Harsh Vardhan,...

Singh said the online outpatient platform will ensure widespread access to quality health services in remote areas besides reducing the loa...

“2DG is an oral antiviral drug that can be administered only upon prescription to hospitalized moderate to severe Covid-19 patients as adju...

The first batch of an Indian developed drug for Covid-19 patients that promises to reduce hospital stay and oxygen dependency was officiall...

The Drugs Controller General of India (DGCI) approved the 2-deoxy-D-glucose (2-DG) drug for emergency use as an adjunct therapy in moderate...

The drug is used as an adjunct therapy. Adjunctive therapy is administered along with the primary treatment.

The first batch of 10,000 doses of 2DG medicine would be launched early next week, informed Defence Research and Development Organisation o...

Shares of Dr. Reddy's Laboratories soared 5 per cent to Rs 5422 on Monday. The scrip was closed at Rs 5173.55 in the previous session. Howe...

The Institute of Nuclear Medicine and Allied Sciences, a DRDO lab, worked in partnership with Dr Reddy’s Laboratories to develop the drug, ...

According to Defence Research and Development Organisation (DRDO) statement, an anti-COVID-19 therapeutic application of the drug 2-deoxy-D...

Giving details, Manohar Parrikar in a written reply said the poly-herbal formulation comprises of ointment and oral dose.